Evotec SE
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibr…
Drug Manufacturers - Specialty & Generic
DE, Hamburg [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Evotec SE (EVO) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers—Specialty & Generic Average | - - | - - | - - | 228,398.64 | 39,681.89 | 1,657.73 | 60,841.10 | -347.38 | 0.01 | 43.9990 | 84.78 | 0.4355 | -0.3727 | 0.01 | 0.02 | 2.3881 | - - | ||
| Maximum | - - | - - | - - | 8,626,028.00 | 528,312.00 | 32,061.00 | 1,988,352.00 | 16,134.00 | 0.08 | 2,279.6263 | 3,215.80 | 1.0000 | 1.6542 | 0.13 | 1.46 | 35.1990 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -15,489.00 | -277,041.00 | -30,106.00 | 0.00 | -1,306.5021 | -853.08 | -3.9254 | -42.3731 | -0.31 | -0.90 | 0.0000 | - - | ||
| Neurocrine Biosciences, Inc. NBIX | 125.65 | 0.65 0.52% | 1,181 vs. 1,016 | 12,721.00 | 515.00 | 43.00 | 119.00 | -113.00 | 0.4300 | 81.2772 | 0.0000 | 0.9752 | 0.0842 | 0.0182 | 0.0125 | 2.3303 | 101.00 | ||
| Evotec SE EVOTF | 6.77 | 0.00 0.00% | 1 vs. 0 | 1,200.00 | 208.00 | -20.00 | -86.00 | -496.00 | -0.1200 | -20.3101 | 0.0000 | 0.1665 | -0.0990 | -0.0187 | -0.0094 | 1.6337 | 177.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.